Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.
3.

The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis.

Wang G, Dong Z, Xu G, Yang Z, Shou C, Wang N, Liu T.

J Cancer Res Clin Oncol. 1998;124(11):615-20.

PMID:
9860290
4.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
5.

VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.

Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY.

Surgery. 2002 Dec;132(6):1056-63; discussion 1063.

PMID:
12490855
7.

Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.

Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM.

Nat Med. 2003 Aug;9(8):1026-32. Epub 2003 Jul 20.

PMID:
12872165
8.

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.

Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.

Oncogene. 2003 Jan 23;22(3):319-29.

PMID:
12545153
10.

Variable sensitivity of endothelial cells to epirubicin in xenografts of human nasopharyngeal carcinoma CNE-2 cells.

Zhang XS, Zhu XF, Gao JS, Ye YL, Feng QS, Liu ZC, Zeng YX.

Cancer Biol Ther. 2002 May-Jun;1(3):263-5.

PMID:
12432274
11.

Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC).

Oshika Y, Nakamura M, Tokunaga T, Ohnishi Y, Abe Y, Tsuchida T, Tomii Y, Kijima H, Yamazaki H, Ozeki Y, Tamaoki N, Ueyama Y.

Eur J Cancer. 2000 Dec;36(18):2390-6.

PMID:
11094315
12.

[The effect of antibody against vascular endothelial growth factor (VEGF) on tumor metastasis].

Wang G, Yang Z, Shou C.

Zhonghua Zhong Liu Za Zhi. 1997 Nov;19(6):407-9. Chinese.

PMID:
10920868
13.

Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).

Ishii H, Yazawa T, Sato H, Suzuki T, Ikeda M, Hayashi Y, Takanashi Y, Kitamura H.

Lung Cancer. 2004 Sep;45(3):325-37.

PMID:
15301873
14.

Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.

Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M.

Oncol Rep. 2003 Jan-Feb;10(1):89-95.

PMID:
12469150
15.

Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.

Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY.

Oncogene. 2003 Mar 13;22(10):1517-27.

PMID:
12629515
16.

Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.

McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandel JJ, Middlesworth W.

J Pediatr Surg. 2003 Mar;38(3):308-14; discussion 308-14.

PMID:
12632340
18.

Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.

Keyes KA, Mann L, Cox K, Treadway P, Iversen P, Chen YF, Teicher BA.

Cancer Chemother Pharmacol. 2003 Apr;51(4):321-7. Epub 2003 Mar 18.

PMID:
12721760
19.

[Experimental study of anti-vascular endothelial growth factor hairpin ribozyme gene inhibiting growth of xenografted tumor of ovarian cancer cells].

Yan R, Xin X, Jin M, Hui H, Wang J, Wang D.

Zhonghua Fu Chan Ke Za Zhi. 2002 Nov;37(11):683-6. Chinese.

PMID:
12487926
20.

Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer.

Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Yamashita H, Fukuda M.

Breast Cancer. 2003;10(2):120-8.

PMID:
12736564

Supplemental Content

Support Center